Tizanidine 51655-0603-20
- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 19, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA076286
Need to source Tizanidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tizanidine Hydrochloride | 4 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
51655-0603-20Selected20 TABLET in 1 BOTTLE, PLASTIC (51655-603-20)
Other packages for this product(3)
90 TABLET in 1 BOTTLE, PLASTIC (51655-603-26)
30 TABLET in 1 BOTTLE, PLASTIC (51655-603-52)
15 TABLET in 1 BOTTLE, PLASTIC (51655-603-54)